UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000049848
Receipt number R000056783
Scientific Title Influence of SGLT2 inhibitors on the efficiency of peritoneal dialysis
Date of disclosure of the study information 2023/01/26
Last modified on 2024/08/03 07:58:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Influence of SGLT2 inhibitors on the efficiency of peritoneal dialysis

Acronym

SGLT2 inhibitors in PD

Scientific Title

Influence of SGLT2 inhibitors on the efficiency of peritoneal dialysis

Scientific Title:Acronym

SGLT2 inhibitors in PD

Region

Japan


Condition

Condition

Chronic kidney disease under peritoneal dialysis

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the possible influence of SGLT2 inhibitors on the efficiency of peritoneal dialysis.

Basic objectives2

Others

Basic objectives -Others

Sugar level in the peritoneal dialysate

Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

peritoneal equilibration test on the day of administration

Key secondary outcomes

Blood sugar level on the day of administration


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Administration of SGLT2 inhibitors

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Chronic kidney disease patients under peritoneal dialysis

Key exclusion criteria

Peritonitis or intraperitoneal cancers

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Masayuki
Middle name
Last name Tanemoto

Organization

International University of Health and Welfare

Division name

Nephrology

Zip code

413-0012

Address

13-1 Higashi-Kaigan-Cho, Atami

TEL

0557819171

Email

mtanemoto-tky@umin.ac.jp


Public contact

Name of contact person

1st name Masayuki
Middle name
Last name Tanemoto

Organization

International University of Health and Welfare

Division name

Nephrology

Zip code

413-0012

Address

13-1 Higashi-Kaigan-Cho, Atami

TEL

0557819171

Homepage URL


Email

mtanemoto-tky@umin.ac.jp


Sponsor or person

Institute

International University of Health and Welfare

Institute

Department

Personal name



Funding Source

Organization

Self

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

International University of Health and Welfare Atami Hospital

Address

13-1 Higashi-Kaigan-Cho, Atami

Tel

0557819171

Email

na-ayumi@iuhw.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 01 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2023 Year 01 Month 26 Day

Date of IRB

2023 Year 01 Month 15 Day

Anticipated trial start date

2023 Year 02 Month 01 Day

Last follow-up date

2024 Year 01 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 12 Month 21 Day

Last modified on

2024 Year 08 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056783